Coronavirus News and Research

RSS

COVID-19 virus and antibodies can coexist in young patients, shows study

With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.

3 Sep 2020

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations.

3 Sep 2020

Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine

A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research suggests.

3 Sep 2020

Avacta enters into manufacturing agreement with Abingdon Health for rapid SARS-CoV-2 antigen test

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.

From Avacta Life Sciences Ltd. 3 Sep 2020

Protocols for minimizing risk in COVID-19 bronchoscopy

One area, discussed in a recent paper by Northwestern University researchers and published on the preprint server medRxiv* in August 2020, is the viral exposure suffered by healthcare workers during bronchoalveolar lavage (BAL).

3 Sep 2020

Study shows why coronavirus is more dangerous in people with comorbidities

Why is the COVID-19 virus more dangerous in people with comorbidities?. Sadis Matalon, Ph.D., of the University of Alabama at Birmingham and colleagues in Texas and San Francisco asked that question in a hypothesis paper published online in Physiological Reviews on March 27.

3 Sep 2020

Researchers assess impact of coronavirus disease on individuals with progressive multiple sclerosis

Researchers conducting a large international study of progressive multiple sclerosis (MS) examined the impact of the global outbreak of coronavirus disease 2019 (COVID-19) on their study participants.

3 Sep 2020

Antibody responses in recovered COVID-19 individuals from India

India has been hit hard by COVID-19, with at least 66,000 deaths and almost 4 million cases. The need to understand the infection, including the various antibody isotypes, and whether neutralizing antibodies and memory B cells are being produced, has driven much research into the way immunity is developing in Indian patients.

3 Sep 2020

A global study to determine COVID-19 health and psychosocial consequences

The current paper lays out the details of a longitudinal study that aims to follow up COVID-19 patients, including any pre-existing chronic illnesses as well as the medical care they received during their illness. A significant minority of convalescents appears to have prolonged disease sequelae.

3 Sep 2020

Major UK study launched to assess the impact of COVID-19 on cancer patients

A new UK study has been launched to assess the impact of covid-19 on people with cancer.

2 Sep 2020

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.

2 Sep 2020

Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection

A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.

2 Sep 2020

Researchers create new and quicker method of diagnosing diseases

A new and quicker method of diagnosing diseases in patients has been created by researchers at the University of Leeds.

2 Sep 2020

Study shows SARS-CoV-2 jumps back and forth between animals and humans on mink farms

An in-depth investigation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks on 16 mink farms by researchers from the Netherlands revealed that minks might serve as a reservoir for persistent infection in humans. The study is currently available on bioRxiv* preprint server.

2 Sep 2020

Treating critically ill COVID-19 patients with steroid improves chances of recovery

A new international study published today [02 September] has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery.

2 Sep 2020

NIH provides scale-up and manufacturing support for new COVID-19 testing technologies

The National Institutes of Health today announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative.

2 Sep 2020

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

2 Sep 2020

Brazilian state of Maranhão heading towards SARS-CoV-2 herd immunity, say researchers

Researchers at the Federal University of Maranhão, Brazil, have conducted a study suggesting that the state of Maranhão is well on its way to acquiring herd immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

2 Sep 2020

Doubts cast over use of face shields, masks with valves against SARS-CoV-2

Many countries across the globe are experiencing a sharp surge in COVID-19 cases, with the total global case toll reaching more than 25.86 million. Face masks have become one of the most effective means to combat the virus spread, particularly if used in combination with regular hand hygiene and physical distancing.

2 Sep 2020

New emergency program provides mental health care across Colorado

The COVID-19 pandemic's effects run deep - far beyond the virus's immediate infections. From loss of livelihoods to drastic decreases in social connection, people across the country are suffering ongoing emotional strain.

2 Sep 2020

Coronavirus News and Research

COVID-19 virus and antibodies can coexist in young patients, shows study

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine

Avacta enters into manufacturing agreement with Abingdon Health for rapid SARS-CoV-2 antigen test

Protocols for minimizing risk in COVID-19 bronchoscopy

Study shows why coronavirus is more dangerous in people with comorbidities

Researchers assess impact of coronavirus disease on individuals with progressive multiple sclerosis

Antibody responses in recovered COVID-19 individuals from India

A global study to determine COVID-19 health and psychosocial consequences

Major UK study launched to assess the impact of COVID-19 on cancer patients

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection

Researchers create new and quicker method of diagnosing diseases

Study shows SARS-CoV-2 jumps back and forth between animals and humans on mink farms

Treating critically ill COVID-19 patients with steroid improves chances of recovery

NIH provides scale-up and manufacturing support for new COVID-19 testing technologies

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Brazilian state of Maranhão heading towards SARS-CoV-2 herd immunity, say researchers

Doubts cast over use of face shields, masks with valves against SARS-CoV-2

New emergency program provides mental health care across Colorado

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News